$AARD
Aardvark Therapeutics, Inc. Common Stock
XNAS•Health Care•Pharmaceutical Preparations
$1.40
▼-64.56%-$2.55
Subscriptions are live. Early access $24.99/mo, or start with 5 free premium days.
Plans & pricingDonateAardvark Therapeutics, Inc. Common Stock
XNAS•Health Care•Pharmaceutical Preparations
Why is AARD down today? It is at $1.40 (-64.56%), and our scanner flagged it 54 times on unusual volume this month. See the catalyst behind the move, real-time alerts the moment AARD spikes, and full due diligence on AARD — key stats, earnings, dilution and insider activity. Free.
Our scanner flagged $AARD 54 times in the last 30 days. Create a free account to track $AARD, build a watchlist, and get instant unusual-volume alerts, with a full day of premium now and 5 more when you verify your email, no card needed.
No card · 5 premium days · join 800+ traders
The top plays and unusual-volume catches our scanner flags, emailed to you. No account needed.
No spam. Unsubscribe anytime. Not investment advice.
AARD is one of today's most active names, trading on unusually heavy volume (live price and day move above). Our scanner has fired 25 unusual-volume and momentum alerts on AARD today, peaking at 324.3x its normal volume. A recent catalyst in the news: “Aardvark Therapeutics Reports Exploratory Data from the Terminated HERO and Open-Label Extension Trials.”
Likely catalystClinical / FDA update, from the latest SEC filing. Read it →Across every filing on file, supply equal to 1864.3% of the tradeable float is in play - 1864.3% more can still be issued.
Shelf sizes are dollars, so shares are estimated at today's price.
One filing exceeds the whole float, which usually means our share count is stale. Check the filing directly.
At-the-market (ATM) offering active — the company can keep selling new shares into the market over time (ongoing)
36,855,037 new shares · At-the-market (ATM) program — sells new shares into the market gradually over time · About $150.0M in size · Priced at $4.07/share
Sources: float & market cap via Polygon · short interest via FINRA · borrow & shortability via Alpaca · SSR from Reg SHO 201 · filings & dilution via SEC EDGAR · analysts via Nasdaq.
Auto-generated from public data for research and education. Not investment advice.
From the trading subreddits (WallStreetBets, r/stocks and more). Retail chatter, not a signal. Do your own research.
| Insider | Action | Shares | % of position | Owns after | Value | Date |
|---|---|---|---|---|---|---|
Sun Nelson Officer | Sold (automatic/other) | -62K 0.3% of company | sold 64% | 35K | $321K at $5.18 | Sep 11, 26 |
Sun Nelson Officer | Sold (automatic/other) | -15K 0.07% of company | sold 13% | 97K | $74K at $5.00 | Sep 10, 26 |
Lee Tien-Li Officer | Bought (open market) | +7K 0.03% of company | added 0.5% | 1.55M | $101K at $14.48 | Dec 11, 25 |
Sun Nelson Officer | Bought (open market) | +3K 0.01% of company | added 2.8% | 108K | $43K at $14.40 | Dec 11, 25 |
Jones Bryan Officer | Other | 1K | n/a | 1K | $5K at $4.24 | Oct 15, 25 |
Lee Tien-Li Officer | Other | 1K | added <0.1% | 1.54M | $5K at $4.24 | Oct 15, 25 |
Lee Tien-Li Officer | Bought (open market) | +10K 0.05% of company | added 0.7% | 1.54M | $95K at $9.51 | Sep 15, 25 |
Lee Tien-Li Officer | Bought (open market) | +5K 0.02% of company | added 0.3% | 1.53M | $43K at $8.50 | Sep 12, 25 |
Lee Tien-Li Officer | Bought (open market) | +6K 0.03% of company | added 0.4% | 1.53M | $47K at $7.82 | Sep 11, 25 |
Lee Tien-Li Officer | Bought (open market) | +9K 0.04% of company | added 0.6% | 1.52M | $71K at $7.91 | Sep 10, 25 |
Sun Nelson Officer | Bought (open market) | +6K 0.03% of company | added 6.0% | 105K | $48K at $8.07 | Sep 9, 25 |
Lee Tien-Li Officer | Other | 17K 0.08% of company | added 1.2% | 1.51M | $73K at $4.24 | Aug 28, 25 |
Recent Form-4 filings via Nasdaq. Open-market buys are the signal worth watching. Grants and automatic (10b5-1) sells are routine. “% of position” is the share of that insider’s own holding the trade moved. Not investment advice.
Blend of news sentiment, today’s move, and community votes. Not investment advice.
News, unusual-volume alerts, AI-trader trades and community chatter - the whole story, newest first.
The tickers our scanner is lighting up most over the last 48 hours.
Comparable names in pharmaceutical preparations, closest in size first.
AARD is one of today's most active names, trading on unusually heavy volume (live price and day move above). Our scanner has fired 25 unusual-volume and momentum alerts on AARD today, peaking at 324.3x its normal volume. A recent catalyst in the news: “Aardvark Therapeutics Reports Exploratory Data from the Terminated HERO and Open-Label Extension Trials.”
AARD last traded at $1.40, down 64.56% on the day. The price and chart above update live during market hours (4 AM to 8 PM ET).
Aardvark Therapeutics, Inc. Common Stock (AARD) is next expected to report earnings on Thursday, November 12, 2026, about 20 days away. Earnings reports often cause large overnight gaps, so many traders manage risk around the date. The date can shift until the company officially confirms it.
The AARD Live Alerts panel on this page streams real-time unusual volume (RVOL), momentum, halt and 200-EMA alerts from our scanner the moment they fire. Our scanner has flagged AARD 54 times in the last 30 days.
AARD (Aardvark Therapeutics, Inc. Common Stock) trades on XNAS, with a market cap of about $86M in the Pharmaceutical Preparations sector.
That depends on your strategy and risk. Day traders look for volume, volatility and a clear trend. Use the live chart, RVOL alerts and 200-EMA context on this page to judge AARD for yourself. This is not investment advice.
Live data from TheDesperateTrader scanner. Not investment advice.
$AARD discussion
Sign in to ask a question or join the discussion.